Dr. Iyengar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Avenue
New York, NY 10065Phone+1 212-639-5159
Education & Training
- University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2006 - 2010
- University of Texas Health Science Center at HoustonInternship, Internal Medicine, 2005 - 2006
- Albert Einstein College of MedicineClass of 2005
- Massachusetts Institute of TechnologyB.S., 1993 - 1997
Certifications & Licensure
- FL State Medical License 2023 - Present
- NJ State Medical License 2023 - 2025
- NY State Medical License 2023 - 2025
- TX State Medical License 2010 - 2023
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Educator of the Year Teaching Award ARRO (Association of Residents in Radiation Oncology), 2016
- Translational Research Award Sidney Kimmel Cancer Research Foundation, 2013
- President's Research Council Award Winner UT Southwestern Medical Center, 2012
- Join now to see all
Clinical Trials
- Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial Start of enrollment: 2014 Feb 01
- Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer Start of enrollment: 2017 Apr 07
- PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors Start of enrollment: 2013 Nov 26
- Join now to see all
Publications & Presentations
PubMed
- 172 citationsSmall Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.Apar Kishor P Ganti, Billy W Loo, Michael Bassetti, Collin Blakely, Anne Chiang
Journal of the National Comprehensive Cancer Network. 2021-12-01 - 331 citationsDefining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus documentYolande Lievens, Matthias Guckenberger, Daniel R. Gomez, Morten Høyer, Puneeth Iyengar
Radiotherapy and Oncology. 2020-07-01 - 665 citationsConsolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.Puneeth Iyengar, Zabi Wardak, David E. Gerber, Vasu Tumati, Chul Ahn
JAMA Oncology. 2018-01-11
Journal Articles
- Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical TrialIyengar P, Wardak Z, Gerber DE, Tumati V, Ahn C, Hughes RS, Dowell JE, Cheedella N, Nedzi L, Westover KD, Pulipparacharuvil S, Choy H, Timmerman RD, JAMA Oncol, 1/11/2018
- Shell feature: a new radiomics descriptor for predicting distant failure after radiotherapy in non-small cell lung cancer and cervix cancerHao H, Zhou Z, Li S, Maquilan G, Folkert MR, Iyengar P, Westover KD, Albuquerque K, Liu F, Choy H, Timmerman R, Yang L, Wang J, Phys Med Biol, 1/2/2018
- Adipocyte Xbp1s overexpression drives uridine production and reduces obesityDeng Y, Wang ZV, Gordillo R, Zhu Y, Ali A, Zhang C, Wang X, Shao M, Zhang Z, Iyengar P, Gupta RK, Horton JD, Hill JA, Scherer PE, Mol Metab, 1/2/2018
- Join now to see all
Books/Book Chapters
Lectures
- From Surgery to Radiosurgery: New HorizonsSpezia, Italy - 1/1/2017
- New Developments in Cancer CachexiaBangalore - 1/1/2012
- Respiratory Tumors-Therapy and BiologyDallas - 1/1/2011
- Join now to see all
Press Mentions
- Patient-Centered Approach Recommended for Oligometastatic NSCLCMay 3rd, 2023
- First Guideline for Treating Oligometastatic NSCLCApril 28th, 2023
- ASTRO/ESTRO's Clinical Guideline Offers Recommendations on the Use of Local Therapy for Oligometastatic NSCLCApril 25th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: